Screener
Novavax NVAX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$53.39M-150% | -$9.49M-102% | $17.53M+122% | -$202.38M-66.8% | $106.51M-34.4% | ||
| $3.06M-59.6% | $3.06M-63.3% | $5.13M-59.1% | $6.59M-48.1% | $7.56M-32.1% | ||
| $8.09M-12.2% | $7.72M-24.9% | $7.97M-23.7% | $8.55M-29.0% | $9.21M-34.6% | ||
| -$72.81M+42.9% | -$32.42M+82.5% | -$39.48M+77.2% | —— | -$127.46M-141% | ||
| $588K+11.6% | $1.27M-20.4% | $2.08M+7.5% | $1.36M-0.7% | $527K-81.7% | ||
| $34.9M-68.6% | -$28.36M+61.3% | —— | -$136.53M— | $111.1M+130% | ||
| —— | $46.41M— | $0— | $42.61M— | $0— | ||
| $1.2M+215% | $37.68M+634% | —— | $42.44M— | -$1.04M-100% | ||
| -$36.89M-288% | -$23.13M+91.3% | -$27.31M+36.9% | $0+100% | -$9.5M-105% | ||
| -$73.4M+42.7% | -$33.69M+82.0% | -$41.55M+76.3% | —— | -$127.99M-141% |
FAQ
- How much cash does Novavax generate?
- Novavax (NVAX) generated -$272.2M in operating cash flow over the trailing twelve months.
- What is Novavax's free cash flow?
- After $5.3M of capital expenditures, Novavax's free cash flow was -$276.6M over the trailing twelve months, down 40.4% year over year.
- Where does Novavax's cash flow data come from?
- Every line is extracted from Novavax's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
